Ascribe Bioscience has become the first company based on technology developed at the Boyce Thompson Institute to receive a National Science Foundation Small Business Innovation Research grant.
Cornell’s Institute for African Development, part of the Einaudi Center for International Studies, has created strong bonds with its alumni based on camaraderie, accomplishment and regular networking.
A research team led by David Russell from the College of Veterinary Medicine has pinpointed a novel angle of attack that could eradicate HIV reservoir cells – while leaving healthy cells untouched.
In his new book “Infinite Powers: How Calculus Reveals the Secrets of the Universe,” mathematician Steven Strogatz explores the history, big ideas and applications of a subject that is essential in everything from how smartphones operate to the latest innovations in medicine.
Five student teams pitched their hospitality-oriented startups at the ninth annual Cornell Hospitality Business Plan Competition March 16 in Statler Auditorium.
Researchers have developed a mathematical model to calculate blameworthiness on a scale from zero to one – a tool that potentially could be used to guide the behavior of artificially intelligent agents, such as driverless vehicles, to help them behave in a “moral” way.
More than 200 alumni are expected to return to campus April 11-12 for the Entrepreneurship at Cornell Celebration, which will include recognition of the Cornell Entrepreneur of the Year.
A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria – a population that shows resistance to traditional flu and polio vaccine.
